Photodynamic therapy utilising topical δ-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin

Acta Ophthalmologica Scandinavica

Volumn 77, Issue 2, 1999, Pages 182-188

  Wang, Ingrid ^a,b   Bauer, Birgitta ^a,b   Andersson Engels, Stefan ^a,c   Svanberg, Sune ^a,c   Svanberg, Katarina ^a,b  

^a Lund University   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Basal cell carcinoma (BCC); Eyelid; Periocular region; Photodynamic therapy (PDT); aminolevulinic acid (ALA)

Indexed keywords

AMINOLEVULINIC ACID; OXYBUPROCAINE; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; EYELID CANCER; EYELID MOVEMENT; FEMALE; FOLLOW UP; HUMAN; LASER; MALE; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PSEUDOPODIUM; SCAR FORMATION; T CELL LYMPHOMA; TOPICAL DRUG ADMINISTRATION;

EID: 0032910545     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1999.770213.x     Document Type: Article

References (34)

1. af Klinteberg C, Nilsson AMK, Wang I, Andersson-Engels S, Svanberg S & Svanberg K (1996): Laser-induced fluorescence diagnostics of basal cell carcinomas of the skin following topical ALA application. In: Bigio, Grundfest, Schneckenburger, Svanberg, and Viallet (eds). Optical Biopsies and Microscopic Techniques, Soc. Photo-Opt. Instrum. Eng., 2926: 32-40.
2. Anderson RL & Ceilley RI (1978): A multispecialty approach to the excision and reconstruction of eyelid tumors. Ophthalmology 85: 1150-1163.
3. Andersson-Engels S, Elner Å, Johansson J, Karlsson S-E, Salford LG, Strömblad L-G, Svanberg K & Svanberg S (1991): Clinical recording of laser-induced fluorescence spectra for evaluation of tumour demarcation feasibility in selected clinical specialities. Lasers Med Sci 6: 415-424.
4. Aurora AL & Blodi FC (1970): Reappraisal of basal cell carcinoma of the eyelids. Am J Ophthalmol 70: 329-336.
5. Bandieramonte G, Marchesini R, Melloni E, Andreoli C, di Pietro S, Spinelli P, Fava G, Zunino F & Emanuelli H (1984): Laser phototherapy following HpD administration in superficial neoplastic lesions. Tumori 70: 327-334.
6. Chalfin J & Putterman AM (1979): Frozen section control in the surgery of basal cell carcinoma of the eyelid. Am J Ophthalmol 87: 802-809.
7. Collin JRO (1976): Basal cell carcinoma in the eyelid region. Br J Ophthalmol 60: 806-809.
8. Dougherty TJ (1981): Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 77: 122-124.
9. Doxanas MT, Green WR & Iliff CE (1981): Factors in the successful surgical management of basal cell carcinoma of the eyelids. Am J Ophthalmol 91: 726-736.
10. El-Sharabasy MMH, El-Waseef AM, Hafez MM & Salim SA (1992): Porphyrin metabolism in some malignant diseases. Br J Cancer 65: 409-412.
11. Fitzpatrick PJ, Thompson GA, Easterbrook WM, Gallie BL & Payne DG (1984): Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radial Oncol Biol Phys 10: 449-454.
12. Frank JF (1989): Frozen section control of excision of eyelid basal cell carcinomas: 8, years' experience. Br J Ophthalmol 73: 328-332.
13. Fraunfelder FT, Zacarian SA, Wingfield DL & Limmer BL (1984): Results of cryotherapy for eyelid malignancies. Am J Ophthalmol 97: 184-188.
14. Hoerauf H, Hüttmann G, Diddens H, Thiele B & Laqua H (1994): Die photodynamische Therapie (PDT) des Lidbasalioms nach topischer Applikation von δ-aminolävulinsäure (ALA). Ophthalmologe 91: 824-829.
15. Kennedy JC & Pottier R (1992): Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14: 275-292.
16. Kennedy JC, Pottier RH & Pross DC (1990): Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B 6: 143-148.
17. Kloek J & Beijersbergen van Henegouwen GMJ (1996): Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 64: 994-1000.
18. Kondo M, Hirota N, Takaoka T & Kajiwara M (1993): Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat. Cell Biol Toxicol 9: 95-105.
19. Lederman M (1976): Radiation treatment of cancer of the eyelids. Br J Ophthalmol 60: 794-805.
20. Mamalis N, White GL, Pedersen DM, Holds J & Anderson RL (1989): Malignant lesions of the eyelid. Am Fam Physician 39: 95-102.
21. Miller SJ (1991): Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 24: 1-13.
22. Navone NM, Frisardi AL, Resnik ER, del C.Batlle AM & Polo CF (1988): Porphyrin biosynthesis in human breast cancer. Preliminary mimetic in vitro studies. Med Sci Res 16: 61-62.
23. Navone NM, Polo CF, Frisardi AL, Andrade NE & del C.Batlle AM (1990): Heme biosynthesis in human breast cancer - mimetic "in vitro" studies and some heme enzymic activity levels. Int J Biochem 22: 1407-1411.
24. Nordman EM, Nordman LEO (1978): Treatment of basal cell carcinoma of the eyelid. Acta Ophthalmologica 56: 349-356.
25. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky K-E & Nesland JM (1997): 5-aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 79: 2282-2308.
26. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM & Giercksky K-E (1995): Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62: 906-913.
27. Rowe DE, Carroll RJ & Day CL (1989): Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patients follow-up. J Dermatol Surg Oncol 15: 315-328.
28. Schlienger P, Brunin F, Desjardins L, Laurent M, Haye C & Vilcoq JR (1996): External radiotherapy for carcinoma of the eyelid: report of 850 cases treated. Int J Radiat Oncol Biol Phys 34: 277-287.
29. Scotto J, Fears TR & Fraumeni JF, Jr. Incidence of nonmelanoma skin cancer in the United States (1983): U.S. Department of Health and Human Services. NIH Publication 83-2433.
30. Svaasand LO, Tromberg BJ, Wyss P, Wyss-Desserich M-T, Tadir Y & Berns MW (1996): Light and drug distribution with topically administered photosensitizers. Lasers Med Sci 11: 261-265.
31. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, Berg R, Johansson J & Svanberg S (1994): Photodynamic therapy of non-melanoma malignant tumours of the skin using top-ical δ-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 130: 743-751.
32. Szeimies R-M, Sassy T & Landthaler M (1994): Penetration potency of topical applied δ-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 59: 73-76.
33. Tse DT, Kersten RC & Anderson RL (1984): Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. Arch Ophthalmol 102: 990-994.
34. v. Domarus H, Stevens PJ (1984): Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10: 1043-1060.